National Cancer Institute

Phayathai, Bangkok 10400

0 studies enrolling now · 1 studies all time

What they study most

NSCLC, Non Small Cell Lung Cancer

Studies at this site

• Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene — Completed